Generate a tailored SOP for Dr. Benjamin Derman. Improve your application with a focused, well-structured draft.
Ben Derman, MD, specializes in hematology oncology. Dr. Derman is an expert in multiple myeloma and plasma cell disorders, including monoclonal gammopathy, amyloidosis, and plasmacytoma. He diagnoses and treats cancerous conditions using innovative techniques, such as CAR T-cell therapy and stem cell transplantation, to deliver long-term success for his patients. In clinical practice, Dr. Derman remains committed to research and is currently focused on identifying strategies that could lead to a possible cure for multiple myeloma. He uses sensitive tests to measure minimal residual disease (MRD) in the body to guide decision-making. Dr. Derman is also investigating new methods and therapies designed to improve outcomes and quality of life for patients. Additionally, he is interested in evaluating the reasons behind racial disparities in multiple myeloma outcomes to better understand patient care. His work has been published in reputable peer-reviewed journals, including the Journal of Immunotherapy of Cancer, Blood, and the Advances in Blood Cancer Journal.
University of Chicago • Chicago, IL
Specializes in hematology oncology, focusing on multiple myeloma and plasma cell disorders.
Department of Philosophy